Welcome to MedArena!

Your trusted destination for CME, CPD & Medical Education across the Middle East.

Information

  • Address:MedArena Corporation
  • Call Us:1 (800) 828-2059
  • Email:support [at] medarenaevents.com
Dr. Hanny Al-Samkari

Achievements

—Associate Professor of Medicine at Harvard Medical School and Attending Classical Hematologist at Massachusetts General Hospital (MGH, Boston, USA).
—Holds an MD from Washington University with board certifications in Internal Medicine and Hematology and fellowship training at MGH/Dana-Farber.
—Plenary Keynote Speaker, Masterclass Director, and Scientific Advisory Board Member for ICCH 2026.

Dr. Hanny Al-Samkari

Associate Professor of Medicine, Classical Hematologist & Clinical Investigator

Harvard Medical School, Massachusetts General Hospital, United States

About

Dr. Hanny Al-Samkari is an internationally recognized classical hematologist, clinical investigator, and Associate Professor of Medicine at Harvard Medical School who has established himself as a world authority on rare bleeding disorders, hereditary hemorrhagic telangiectasia (HHT), immune thrombocytopenia (ITP), and iron deficiency anemia. He earned his Doctor of Medicine (MD) degree from Washington University School of Medicine in St. Louis with highest academic honors. He subsequently completed his internal medicine residency and chief residency at the University of Pennsylvania, followed by advanced subspecialty fellowship training in hematology and medical oncology at Massachusetts General Hospital and Dana-Farber Cancer Institute.

Practicing as an attending classical hematologist at Massachusetts General Hospital (MGH), Dr. Al-Samkari directs dedicated clinical research programs focusing on benign hematologic diseases. His clinical and translational scope encompasses hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome), severe refractory iron deficiency,immune thrombocytopenia, thrombotic microangiopathies (TTP/aHUS), paroxysmal nocturnal hemoglobinuria (PNH),and rare vascular malformation syndromes.

Throughout his academic tenure at Harvard Medical School, Dr. Al-Samkari has pioneered novel therapeutic frameworks for chronic bleeding disorders that were historically managed solely with supportive transfusions. He has spearheaded landmark clinical trials evaluating anti-angiogenic agents—such as systemically administered pazopanib, pomalidomide,and bevacizumab—for the treatment of severe epistaxis and gastrointestinal bleeding in HHT, fundamentally altering international management guidelines for this debilitating inherited condition.

A central pillar of Dr. Al-Samkari’s research leadership is his work in expanding novel biopharmaceutical options for rare blood disorders. Under his principal investigator directorship, clinical trials at MGH have evaluated second-generation thrombopoietin receptor agonists (TPO-RAs), complement pathway inhibitors, and novel intravenous iron formulations,proving that targeted molecular therapies significantly improve patient quality of life and reduce emergency hospitalization rates.

In addition to his clinical research trials and specialized outpatient practice, Dr. Al-Samkari is a dedicated medical educator, academic supervisor, and lecturer at Harvard Medical School. He actively mentors hematology fellows, post-doctoral clinical research scholars, and medical students, directing accredited continuing medical education (CME) seminars, clinical trial design courses, and hematology board review sessions. His teaching philosophy emphasizes rigorous diagnostic methodology, critical appraisal of clinical trial data, and compassionate, evidence-based patient care.

Dr. Al-Samkari is an extraordinarily prolific physician-scientist who has authored over 150 peer-reviewed scientific publications, review articles, and textbook chapters in premier medical journals, including The New England Journal of Medicine (NEJM), The Lancet, Blood, Gastroenterology, and the American Journal of Hematology. His high-impact research portfolio focuses on defining real-world clinical endpoints in rare bleeding disorders, establishing international consensus criteria for HHT-related anemia, evaluating novel iron formulations, and analyzing thrombosis risk profiles in refractory hematologic conditions.

Beyond his institutional responsibilities at MGH and Harvard Medical School, Dr. Al-Samkari actively serves on executive leadership boards, scientific advisory panels, and steering committees for global hematology organizations,including the American Society of Hematology (ASH), the Cure HHT Global Research Network, and the Hemostasis and Thrombosis Research Society (HTRS). He routinely represents global classical hematology as a keynote presenter, course director, and plenary speaker at major international medical congresses across North America, Europe, Asia, and the Middle East.

At the International Classical Hematology Conference 2026 (ICCH 2026), Dr. Hanny Al-Samkari stands out as a core scientific keynote presenter, clinical masterclass director, and advisory board member. Connecting consultant hematologists, clinical researchers, pathologists, and public health strategists, he provides delegates with cutting-edge,evidence-based strategies to optimize rare bleeding disorder management, adopt novel targeted therapeutics, and elevate classical hematology care standards nationwide and across the region.

Events & Activities

International Classical Hematology Conference 2026 | ICCH 2026
Dec 18, 2026
In-Person

International Classical Hematology Conference 2026 | ICCH 2026

MeetingMinds Experts

  • CME/CPD
  • Dusit Thani, Abu Dhabi, United Arab Emirates
Dec 18, 2026
In-Person

International Classical Hematology Conference 2026 | ICCH 2026

USD 150

The 1st International Conference of Classical Hematology (ICCH 2026) brings together regional and international experts in Abu Dhabi to explore the latest advancements, research, and innovations in classical hematology.

MeetingMinds Experts

  • 3 Days
  • Dusit Thani, Abu Dhabi, United Arab Emirates
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education